DK1499349T3 - Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet - Google Patents
Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitetInfo
- Publication number
- DK1499349T3 DK1499349T3 DK02713767.8T DK02713767T DK1499349T3 DK 1499349 T3 DK1499349 T3 DK 1499349T3 DK 02713767 T DK02713767 T DK 02713767T DK 1499349 T3 DK1499349 T3 DK 1499349T3
- Authority
- DK
- Denmark
- Prior art keywords
- allergy
- immunogenicity
- allergen
- hybrid allergen
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43568—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from wasps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Insects & Arthropods (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27281801P | 2001-03-02 | 2001-03-02 | |
PCT/US2002/006765 WO2002070665A2 (en) | 2001-03-02 | 2002-03-04 | Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1499349T3 true DK1499349T3 (da) | 2010-04-06 |
Family
ID=23041432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02713767.8T DK1499349T3 (da) | 2001-03-02 | 2002-03-04 | Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030039660A1 (da) |
EP (1) | EP1499349B1 (da) |
JP (1) | JP2005508134A (da) |
CN (1) | CN1610556A (da) |
AT (1) | ATE448793T1 (da) |
CA (1) | CA2441476A1 (da) |
DE (1) | DE60234475D1 (da) |
DK (1) | DK1499349T3 (da) |
WO (1) | WO2002070665A2 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1714153A (zh) * | 2002-11-01 | 2005-12-28 | 阿尔克-阿贝洛有限公司 | 重组蛋白质变异体 |
ATE486936T1 (de) * | 2003-03-05 | 2010-11-15 | Chemo Sero Therapeut Res Inst | Verfahren zur herstellung eines heterologen proteins in e. coli |
CA2543072A1 (en) * | 2003-11-05 | 2005-06-02 | Pevion Biotech Ltd. | Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
BRPI0608455A2 (pt) | 2005-03-18 | 2010-01-05 | Cytos Biotechnology Ag | composição compreendendo conjugados de alérgenos de gato bem como vacinas, composições farmacêuticas e medicamentos contendo a mesma, e processo para sua produção |
EP2692732A1 (en) | 2012-08-03 | 2014-02-05 | Stallergenes S.A. | Novel allergen from ragweed pollen and uses thereof |
US10799573B2 (en) * | 2016-03-30 | 2020-10-13 | Regents Of The University Of Minnesota | Pertussis vaccines and methods of making and using |
EP3844289A4 (en) * | 2018-08-29 | 2022-07-20 | Shanghaitech University | COMPOSITION AND USE OF CAS PROTEIN INHIBITORS |
CN115697069A (zh) * | 2020-02-19 | 2023-02-03 | 完美日股份有限公司 | 低变应原性重组乳蛋白和包含其的组合物 |
CN113173982B (zh) * | 2021-04-14 | 2022-09-06 | 中国海洋大学 | Rap v 2蛋白相关的抗原表位肽及其应用 |
CN114685636B (zh) * | 2022-03-04 | 2024-03-01 | 首都医科大学附属北京同仁医院 | 蒿属植物花粉过敏原、应用及试剂盒 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
EP0550553B1 (en) | 1990-09-25 | 2000-07-12 | Cantab Pharmaceuticals Research Limited | Viral defective vaccine produced by transcomplementing cell line |
US5593877A (en) | 1993-03-11 | 1997-01-14 | The Rockefeller University | Nucleic acid and recombinant production of vespid venom hyaluronidase |
AU696336B2 (en) | 1993-03-19 | 1998-09-10 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. HSV) as vaccine |
FR2714830B1 (fr) | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
WO1995028494A1 (en) | 1994-04-15 | 1995-10-26 | Targeted Genetics Corporation | Gene delivery fusion proteins |
FR2727679B1 (fr) | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
US5804201A (en) | 1996-03-11 | 1998-09-08 | The Rockefeller University | Immunomodulatory peptides of vespid antigen 5 |
US6432699B1 (en) | 1997-03-28 | 2002-08-13 | New York University | Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
US6528315B2 (en) | 1997-06-30 | 2003-03-04 | Aventis Pharma S.A. | Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
PL337617A1 (en) | 1997-06-30 | 2000-08-28 | Rhone Poulenc Rorer Sa | Apparatus for performing optimised in vivo electrotransfer of vectorial nucleic acids into tissues |
IL133710A0 (en) | 1997-06-30 | 2001-04-30 | Rhone Poulence Rorer S A | Improved method for transferring nucleic acid into the striped muscle and combination thereof |
CN1332029C (zh) * | 1998-03-16 | 2007-08-15 | 阿尔克-阿贝洛有限公司 | 突变的重组过敏原 |
CA2396422A1 (en) * | 2000-01-06 | 2001-07-12 | Monsanto Technology Llc | Preparation of deallergenized proteins and permuteins |
CN1714153A (zh) * | 2002-11-01 | 2005-12-28 | 阿尔克-阿贝洛有限公司 | 重组蛋白质变异体 |
-
2002
- 2002-03-04 EP EP02713767A patent/EP1499349B1/en not_active Expired - Lifetime
- 2002-03-04 US US10/091,135 patent/US20030039660A1/en not_active Abandoned
- 2002-03-04 JP JP2002570693A patent/JP2005508134A/ja active Pending
- 2002-03-04 DE DE60234475T patent/DE60234475D1/de not_active Expired - Lifetime
- 2002-03-04 WO PCT/US2002/006765 patent/WO2002070665A2/en active Application Filing
- 2002-03-04 CN CNA02809204XA patent/CN1610556A/zh active Pending
- 2002-03-04 AT AT02713767T patent/ATE448793T1/de not_active IP Right Cessation
- 2002-03-04 CA CA002441476A patent/CA2441476A1/en not_active Abandoned
- 2002-03-04 DK DK02713767.8T patent/DK1499349T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1499349A4 (en) | 2005-11-16 |
EP1499349B1 (en) | 2009-11-18 |
WO2002070665A8 (en) | 2004-12-16 |
US20030039660A1 (en) | 2003-02-27 |
CA2441476A1 (en) | 2002-09-12 |
CN1610556A (zh) | 2005-04-27 |
WO2002070665A3 (en) | 2004-11-11 |
JP2005508134A (ja) | 2005-03-31 |
DE60234475D1 (de) | 2009-12-31 |
ATE448793T1 (de) | 2009-12-15 |
EP1499349A2 (en) | 2005-01-26 |
WO2002070665A2 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1114265T1 (el) | Πρωτεϊνη συντηξης αλβουμινης | |
DE60235039D1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
EP1847549A3 (en) | Papillomavirus polyprotein constructs | |
ATE557041T1 (de) | Peptid-vakzinen gegen streptokokken der gruppe a | |
DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
WO2002014358A3 (en) | Novel secreted proteins and their uses | |
DK1194560T3 (da) | Antigene Neisseria-peptider | |
DE60039050D1 (de) | Antigene meningokokken peptide | |
WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
DK1349944T3 (da) | Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens | |
DK1499349T3 (da) | Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet | |
ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
DK1530637T3 (da) | Carlsberg-subtilisin-proteiner med nedsat immunogenitet | |
DE69836744D1 (de) | Gruppe a streptokokken-impfstoff | |
GB0113798D0 (en) | Antigens and vectors for vaccination | |
ATE326981T1 (de) | Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
ATE469655T1 (de) | Bakteriophagenvermittelte impfung | |
DE60236330D1 (de) | Biologisch aktive Peptide | |
RU2215005C2 (ru) | Регуляторные/развернутые пептиды эзрина | |
WO2002044202A3 (fr) | Peptides immunogeniques mutes derives de r9m, polynucleotides les codant et leurs usages therapeutiques | |
DK1219299T4 (da) | Allergivacciner og fremstilling deraf | |
WO2002016578A3 (en) | Secreted proteins and methods of using same | |
TH78666B (th) | วัคซีนรีคอมบิแนนท์แวคซิเนียไวรัส | |
ATE328897T1 (de) | Verwendung von hev-polypeptiden | |
WO1997039020A3 (en) | Antigenic sequences of a sperm protein and immunocontraceptive methods |